Zytomics
Aguardando apresentação ou exame de recurso contra o deferimento parcial de Designação Recebida
Marca Nominativa depositada no INPI em
01/11/2023 por ZytoVision GmbH,
processo nº 501779736, nas classes 01, 05, 09, 10, 35, 42, 44.
O processo ainda está em andamento no INPI.
| Número do processo | 501779736 |
|---|
| Situação | Aguardando apresentação ou exame de recurso contra o deferimento parcial de Designação Recebida |
|---|
| Apresentação | Nominativa |
|---|
| Natureza | Madri
Produto/Serviço |
|---|
| Data do depósito | 01/11/2023 |
|---|
| Data da concessão | — |
|---|
| Vigência até | 01/11/2033 |
|---|
| Titular | ZytoVision GmbH |
|---|
| CNPJ/CPF do titular | — |
|---|
| UF · País | — · DE |
|---|
Classes e especificação
Chemicals for use in industry and science; chemicals, biochemicals, for use in the following fields: pathology, genetics, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology, laboratory medicine; chemicals and biochemicals for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including dna, rna and proteins; nucleic acids (including dna, rna, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, dna probes being biochemical substances, rna probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers.;
Pharmaceuticals and medical preparations; medical preparations for diagnostics; medical preparations for in-vitro diagnostics; pharmaceuticals, pharmaceutical preparations, medical preparations, chemical products, chemical preparations, biochemical products, biochemical preparations, for medical use; pharmaceutical, medicated, chemical and biochemicals and preparations for medical purposes for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including dna, rna and proteins; nucleic acids (including dna, rna, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, dna probes being biochemical substances, rna probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers.;
Scientific research and laboratory apparatus, educational apparatus and simulators; analysis apparatus for conducting and evaluating histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, PCR (polymerase chain reaction), NGS (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry and isolation of biomolecules including DNA, RNA and proteins; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, analysis apparatus for research laboratories for measuring, testing and examining tissue, cells and biomolecules including DNA, RNA and proteins.;
Medical apparatus and instruments; medical instruments; medical analytical apparatus for medical purposes; automatic analyzers for medical diagnosis; physical analyzers for medical use; genetic testing apparatus for medical purposes.;
Business management consultancy and advisory services; operation of businesses [for others]; running of a holding company, namely business management, business administration, office functions; holding company services, namely marketing strategy, professional business and organisational consultancy and management of the business interests of others and legally independent companies; business management and organization consultancy; advisory services for business management; business administration; office functions; planning and monitoring of business developments with regard to organisational matters.;
Science and technology services; medical laboratory services; medical research laboratory services; development of pharmaceutical preparations and medicines; clinical research; research relating to biotechnology; scientific consultancy services; biological analysis, biochemical analysis, chemical analysis, scientific analysis; scientific research in the field of genetics and genetic engineering.;
Medical services; medical diagnostic services; in-vitro diagnostic services for medical and pharmaceutical use; medical services, in relation to the following fields: pathology, genetic science, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology and laboratory medicine; medical services by means of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry and isolation of biomolecules including dna, rna and proteins; medical counseling; pharmaceutical services; pharmaceutical advice; medical and health services relating to dna, genetics and genetic testing; pathology services; genetic testing for medical purposes.;